Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.72 |
| ▸ | MAPT | P10636 | 4/20 | 0.72 |
| ▸ | MEN1 | O00255 | 4/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | FNTA | P49354 | 1/20 | 0.59 |
| ▸ | FNTB | P49356 | 1/20 | 0.59 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.57 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29466101 | 1.00 | PKM (0.73) | PKMKMT2AMAPTMEN1ALDH1A1 | |
| Benzoyl Formic Acid SCHEMBL31275394 | 0.89 | KMT2A (0.62) | PKMKMT2AMAPTMEN1ALDH1A1 | |
| Indole-3-Acetic Acid SCHEMBL28331401 | 0.86 | TDP1 (0.57) | PKMKMT2AMAPTMEN1ALDH1A1 | |
| SCHEMBL4781191 | 0.85 | MAPT (0.74) | PKMKMT2AMAPTMEN1ALDH1A1 | |
| SCHEMBL7640139 | 0.84 | KMT2A (0.68) | PKMKMT2AMAPTMEN1ALDH1A1 | |
| Methyl 3-(3-Indolylmethyl)Propanoate SCHEMBL290808 | 0.84 | MAPT (0.71) | PKMKMT2AMAPTMEN1ALDH1A1 | |
| SCHEMBL361312 | 0.84 | PKM (1.00) | PKMKMT2AMAPTMEN1ALDH1A1 | |
| SCHEMBL30419025 | 0.84 | PKM (1.00) | PKMKMT2AMAPTMEN1ALDH1A1 | |
| SCHEMBL29664021 | 0.84 | MAPT (0.66) | PKMKMT2AMAPTMEN1ALDH1A1 | |
| SCHEMBL6965640 | 0.84 | MAPT (0.72) | PKMKMT2AMAPTMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 609 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| CN-119874598-A | Indole-3-acetamide derivative and preparation method and application thereof | 河北农业大学 | 2025-04-25 | — | — | CN | claimed |
| CN-119699343-A | Tobacco bud inhibitor and preparation method thereof | 云南省烟草公司曲靖市公司 | 2025-03-28 | — | — | CN | claimed |
| CN-115598249-B | Detection method and detection kit for phytohormone and application of detection method and detection kit | 苏州帕诺米克生物医药科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| EP-4424365-A2 | PET FOOD COMPOSITIONS | Hill's Pet Nutrition, Inc. (US) | 2024-09-04 | — | — | EP | claimed |
| EP-4017281-B1 | PET FOOD COMPOSITIONS | HILLS PET NUTRITION INC (US) | 2024-08-28 | — | — | EP | claimed |
| CN-118530176-A | Synthesis method of ester-substituted isoquinoline diketone and 3, 3-disubstituted indole oxide | 新疆大学 | 2024-08-23 | — | — | CN | claimed |
| CN-115919847-B | Application of indole-3-methyl acetate in relieving radiation-induced pulmonary fibrosis | 中南大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117310059-B | Plasma metabolism marker combination for early diagnosis or monitoring of Crohn disease and application thereof | 中国人民解放军总医院 | 2024-02-02 | — | — | CN | claimed |
| WO-2012140603-A1 | METHOD FOR PROFILING PHYTOHORMONE LEVELS IN PLANT TISSUE | BASF PLANT SCIENCE COMPANY GMBH (DE) | 2012-10-18 | — | — | WO | claimed |
| US-20120108431-A1 | PLANT GROWTH REGULATOR ADDITIVE | TAMINCO, NAAMLOZE VENNOOTSCHAP (BE) | 2012-05-03 | — | — | US | claimed |
| CN-102438453-A | Plant growth regulator additive | TAMINCO NV | 2012-05-02 | — | — | CN | claimed |
| EP-2416653-A2 | PLANT GROWTH REGULATOR ADDITIVE | Taminco, Naamloze Vennootschap (BE) | 2012-02-15 | — | — | EP | claimed |
| WO-2010116259-A2 | PLANT GROWTH REGULATOR ADDITIVE | TAMINCO, NAAMLOZE VENNOOTSCHAP (BE) | 2010-10-14 | — | — | WO | claimed |
| CN-101217999-A | Personal care compositions and methods for the beautification of mammalian skin and hair | PROCTER & GAMBLE (US) | 2008-07-09 | — | — | CN | claimed |
| EP-1901817-A2 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | The Procter and Gamble Company (US) | 2008-03-26 | — | — | EP | claimed |
| WO-2007007255-A2 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-18 | — | — | WO | claimed |
| US-20070009474-A1 | Personal care compositions and methods for the beautification of mammalian skin and hair | THE PROCTER & GAMBLE COMPANY | 2007-01-11 | — | — | US | claimed |
| EP-1329160-A2 | 4-ACYLAMINOPYRAZOLE DERIVATIVES | Sankyo Company, Limited (JP) | 2003-07-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108431-A1 | PLANT GROWTH REGULATOR ADDITIVE | MYB, ING2, AGXT | PKM 2817/4885KMT2A 710/4885MAPT 4726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.